Monday, September 30, 2013

• pSivida Announces That U.K.’s NICE Recommends ILUVIEN® for Chronic Diabetic Macular Edema in Pseudophakic Eyes; NHS Reimbursement Expected to FollowBusiness Wire (Mon, Sep 30)
• Five FDA Approvals and Reviews at Risk Under a Government Shutdown24/7 Wall St. (Mon, Sep 30)

Friday, September 27, 2013

• PSIVIDA CORP. Files SEC form 10-K, Annual ReportEDGAR Online (Fri, Sep 27)
• pSivida to Present at 4th Annual Conference on Biosimilars & BiobettersBusiness Wire (Fri, Sep 27)

Wednesday, September 25, 2013

• pSivida Corp.'s CEO Discusses F4Q 2013 Results - Earnings Call Transcriptat Seeking Alpha (Wed, Sep 25)
• pSivida Corp. Discusses Q4 2013 Results (Webcast)at Seeking Alpha (Wed, Sep 25)
• PSIVIDA CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online (Wed, Sep 25)
• pSivida Corp. Reports Fourth Quarter and Fiscal Year 2013 ResultsBusiness Wire (Wed, Sep 25)
• Q4 2013 pSivida Corp. Earnings Release - After Market CloseCCBN (Wed, Sep 25)

Wednesday, September 18, 2013

• pSivida Corp. Announces Fourth Quarter and Fiscal Year 2013 Financial Results Release Date and Conference Call InformationBusiness Wire (Wed, Sep 18)

Monday, September 16, 2013

• A Closer Look At PSivida's Pipelineat Seeking Alpha (Mon, Sep 16)

Wednesday, September 4, 2013

• pSivida to Present At Two Investment Conferences in SeptemberBusiness Wire (Wed, Sep 4)

Friday, August 30, 2013

• The Fundamental Danger To Biotech And How pSivida's Model Can Help Address Itat Seeking Alpha (Fri, Aug 30)

Wednesday, August 28, 2013

• Alimera, pSivida Eye Drug Warrants FDA Approval On Third Tryat TheStreet (Wed, Aug 28)

Thursday, August 15, 2013

• Iluvien And Tethadur: Sustained Release Treatments With Big Potential For pSividaat Seeking Alpha (Thu, Aug 15)

Monday, August 5, 2013

• pSivida Corp - Sustained Release Biologics: The Missing PieceAccesswire (Mon, Aug 5)

Monday, July 29, 2013

• pSivida CEO to Discuss Sustained Delivery of Antibodies in Ophthalmology and Systemic Disease at International Symposium on Integrated FunctionalitiesBusiness Wire (Mon, Jul 29)

Wednesday, July 24, 2013

• pSivida announces positive opinion for reimbursement of ILUVIEN in Francetheflyonthewall.com (Wed, Jul 24)
• pSivida Announces France’s Transparency Commission Issues Positive Opinion for Reimbursement of ILUVIENBusiness Wire (Wed, Jul 24)

Friday, July 19, 2013

• pSivida 3.495M share Secondary priced at $3.10theflyonthewall.com (Fri, Jul 19)
• pSivida Announces Pricing of $10.8 Million Offering of Common StockBusiness Wire (Fri, Jul 19)
• PSIVIDA CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial StaEDGAR Online (Fri, Jul 19)

Thursday, July 18, 2013

• pSivida Announces Proposed Public Offering of Common StockBusiness Wire (Thu, Jul 18)

Tuesday, July 16, 2013

• pSivida Up on Phase I/II Interim DataZacks (Tue, Jul 16)

Thursday, July 11, 2013

• pSivida says 'very happy' with early data from uveitis studyat theflyonthewall.com (Thu, Jul 11)

Add PSDV News to My Yahoo!